Obstetric Outcomes After Double Embryo Transfer

June 7, 2024 updated by: Ahmed Shehata Mohamed Ismail, Assiut University

Obstetric Outcomes After Double Embryo Transfer in Intracytoplasmic Sperm Injection

Aim ; to compare obstetric outcomes in relation to number of embryo transfer in ICSI

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

Assisted reproductive technology with intracytoplasmic sperm injection (ICSI) and IVF is becoming an international direction for couples struggling with infertility. The increasing popularity and frequency of these techniques and the data generated from it has given us a better overview of the efficacy, consequences and costs of these techniques.

The aim of assisted reproductive technology (ART) is to achieve pregnancy while decreasing the risk of multiple gestations. When compared with elective single embryo transfer (SET), double embryo transfer (DET) demonstrates a superior pregnancy and live birth rate with a significantly higher risk of multiple gestations. The high frequency of multiple births is the main factor which leads to adverse outcome in IVF/intracytoplasmic sperm injection (ICSI) treatment. Transfer of two embryos does not diminish the chance of a birth when compared with three embryo transfer. How would be the obstetric outcome in pregnancies resulting from DET in IVF/ICSI cycles.

Despite achieving a higher pregnancy rates, DET in ART leads to an increase in multiple gestation pregnancies, which are associated with increased both maternal and neonatal morbidity and mortality.

Twin pregnancies have a higher incidence of preterm cesarean sections , admissions to the neonatal intensive care unit (NICU), and other maternal complications, when compared with singleton pregnancies. Twin pregnancies have a higher incidence of preterm cesarean sections , admissions to the neonatal intensive care unit (NICU), and other maternal complications, when compared with singleton pregnancies.

Most patients prefer to have two embryos transferred, due to financial considerations being the main reason.

Studies demonstrate that patients are more likely prefer to choose SET when educated about the risks of multiple gestation pregnancy, but select two embryos for transfer if they have a lower pregnancy rate when compared with transferring one embryo .

Cost effectiveness research comparing single versus DET after in vitro fertilization (IVF) has previously been performed, with most studies taking place in areas with mandated IVF insurance coverage, and few incorporating hospital costs linked to obstetrical and neonatal outcomes.

Study Type

Observational

Enrollment (Actual)

927

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Assiut, Egypt
        • Assiut University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

All women have ICSI at IVF unit at AUH

Description

Inclusion Criteria:

  • all patients subjected with ICSI pregnancy

Exclusion Criteria:

  • incomplete data

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Case-Control
  • Time Perspectives: Retrospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Single Embryo Transfer
No interventions
Double embryo transfer
No interventions
3 embryo transfer
No interventions
4 embryo transfer
No interventions

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Live birth
Time Frame: 1 year
Comparison
1 year

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Rate of neonatal morbidities and mortalities in single embryo transfer versus double embryo transfer
Time Frame: 1 year
Comparison
1 year
Rate of miscarriage
Time Frame: 1 year
Comparison
1 year
Rate of admission to NICU
Time Frame: 1 year
Comparison
1 year
Rate of multiple pregnancies
Time Frame: 1 year
Comparison
1 year
Rate of preterm
Time Frame: 1 year
Comparison
1 year
Rate of PPROM
Time Frame: 1 year
Comparison
1 year
Rate of Clinical pregnancy
Time Frame: 1 year
Comparison
1 year
Rate of chemical pregnancy
Time Frame: 1 year
Comparison
1 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Sherif Mohamed Abd Elmageed Badran, Lecturer, Assiut University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 30, 2022

Primary Completion (Actual)

November 1, 2023

Study Completion (Actual)

March 1, 2024

Study Registration Dates

First Submitted

December 12, 2021

First Submitted That Met QC Criteria

April 3, 2022

First Posted (Actual)

April 11, 2022

Study Record Updates

Last Update Posted (Actual)

June 11, 2024

Last Update Submitted That Met QC Criteria

June 7, 2024

Last Verified

June 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • DET in ICSI

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe